Detalles de la búsqueda
1.
Preclinical Metabolism and Disposition of TP0473292, a Novel Oral Prodrug of the Potent Metabotropic Glutamate 2/3 Receptor Antagonist TP0178894 for the Treatment of Depression.
Drug Metab Dispos
; 51(5): 572-582, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754836
2.
Bottom-up physiologically based pharmacokinetic modelling for predicting the human pharmacokinetic profiles of the ester prodrug MGS0274 and its active metabolite MGS0008, a metabotropic glutamate 2/3 receptor agonist.
Xenobiotica
; 52(2): 119-128, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296225
3.
Ozoralizumab, a Humanized Anti-TNFα NANOBODY® Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG.
Front Immunol
; 13: 853008, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35273620
4.
Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability.
Eur J Med Chem
; 203: 112521, 2020 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32698110
5.
Preclinical disposition of MGS0274 besylate, a prodrug of a potent group II metabotropic glutamate receptor agonist MGS0008 for the treatment of schizophrenia.
Pharmacol Res Perspect
; 7(5): e00520, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31523433
Resultados
1 -
5
de 5
1
Próxima >
>>